One of the pathological manifestations of Phenylketonuria (PKU) is the formation of fibrillar assemblies of aromatic amino acid, L-Phenylalanine, at pathological concentrations. As a possible therapeutic strategy for PKU, we introduce gallic acid, a polyphenol, passivated nanocarbon system (CNPGA) with the ability to disrupt and inhibit the formation of fibrillar assemblies.

You have access to this article

Please wait while we load your content... Something went wrong. Try again?